Related Experiment Videos
Dexmedetomidine overdose in the perioperative setting.
Victor S B Jorden1, Robert M Pousman, Mary M Sanford
1Abbott Laboratories, Inc., Abbott Park, IL 60046-6229, USA. victor.jorden@abbott.com
The Annals of Pharmacotherapy
|March 25, 2004
Summary
Accidental dexmedetomidine overdose primarily causes oversedation, resolving quickly due to its short half-life. Hemodynamic stability was observed, but practitioners should carefully manage dosing to avoid adverse events.
Area of Science:
- Anesthesiology
- Pharmacology
- Critical Care Medicine
Background:
- Dexmedetomidine is an alpha-2 adrenergic agonist used for sedation and analgesia.
- Accidental overdoses can occur in perioperative settings, necessitating understanding of its effects.
Observation:
- Three cases of accidental dexmedetomidine overdose are presented: one intraoperative and two postoperative.
- Patients received doses significantly exceeding recommended guidelines.
- Oversedation was the primary clinical manifestation, assessed via clinical observation and bispectral index monitoring.
Findings:
- Hemodynamic parameters remained stable in all overdose cases.
- Oversedation resolved within one hour of discontinuing the drug.
- Naranjo criteria indicated a probable association between dexmedetomidine and the observed oversedation.
Implications:
- Practitioners must be prepared to manage oversedation following dexmedetomidine overdose.
- While hypertension is a potential side effect, it was not consistently observed in these cases.
- Accurate attention to dexmedetomidine dosing units (microg/kg/h vs. microg/kg/min) is crucial to prevent overdose.